Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable ...

Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung ...

From a personalized melanoma vaccine to new options for biliary, stomach, lung and endometrial cancers, here are 5 ESMO 2026 ...

Five colorectal cancer trials recently began treating patients, testing targeted drugs, bispecific antibodies and ...

In this episode of CURE’s Cancer Search Bar, psycho-oncologist Ramy Sedhom, section chief of oncology and palliative care and co-leader of psychosocial oncology services at Penn Medicine Princeton ...

Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch. Beyond the headline Presidential Symposium sessions, ...

A study of 52,236 patients with cancer found that episodes of unintended weight loss affected 46.63% of patients and were tied to shorter overall survival.

Doctors had found cancer cells in her blood, and further testing confirmed a diagnosis of acute lymphoblastic leukemia (ALL). As 8-year-old Harper Harrell began treatment, much of the childhood she ...

CDK4/6 inhibitors — possible colitis: Ibrance, Kisqali (including the Kisqali Femara Co-Pack) and Verzenio. These pills are ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...

Learn how personalized cancer vaccines work and what to watch for at ESMO 2026. A vaccine made from a person’s own tumor has become the first of its kind to succeed in a phase 3 trial. Full results ...